|
GANAB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.473200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.100200E-01 |
| Normal-vs-Stage2 |
7.961200E-01 |
| Normal-vs-Stage3 |
8.314200E-01 |
| Normal-vs-Stage4 |
9.490600E-01 |
| Stage1-vs-Stage2 |
3.317200E-01 |
| Stage1-vs-Stage3 |
3.171400E-01 |
| Stage1-vs-Stage4 |
5.653000E-01 |
| Stage2-vs-Stage3 |
9.379400E-01 |
| Stage2-vs-Stage4 |
8.983200E-01 |
| Stage3-vs-Stage4 |
9.394800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.447400E-01 |
| Normal-vs-AfricanAmerican |
9.980400E-01 |
| Normal-vs-Asian |
5.790600E-01 |
| Caucasian-vs-AfricanAmerican |
4.472800E-01 |
| Caucasian-vs-Asian |
7.234600E-01 |
| AfricanAmerican-vs-Asian |
5.310400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.511800E-02 |
| Normal-vs-Female |
1.090650E-01 |
| Male-vs-Female |
1.903640E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.334400E-01 |
| Normal-vs-Extreme_Weight |
5.359700E-02 |
| Normal-vs-Obese |
9.321000E-01 |
| Normal-vs-Extreme_Obese |
1.620330E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.448630E-01 |
| Normal_Weight-vs-Obese |
8.843400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.126390E-01 |
| Extreme_Weight-vs-Obese |
7.559900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.572600E-01 |
| Obese-vs-Extreme_Obese |
9.336200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.911030E-01 |
| Normal-vs-Age(41-60Yrs) |
6.349800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.098500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.807600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.426810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.762200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.872400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.575800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.312000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.337000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.119000E-01 |
| Normal-VS-Type2 PRCC |
2.622000E-03 |
| Normal-VS-KIRP CIMP |
4.634000E-02 |
| Normal-VS-Unclassified PRCC |
3.498400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.602200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.444200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.161450E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.073820E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.016100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.764300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.070200E-01 |
| Normal-vs-N1 |
3.324800E-01 |
| Normal-vs-N2 |
5.340400E-01 |
| N0-vs-N1 |
1.101410E-01 |
| N0-vs-N2 |
2.099800E-01 |
| N1-vs-N2 |
6.898200E-01 |
|
|
